Results 131 to 140 of about 4,098 (181)

Canonical and Truncated Transglutaminase-2 Drive TGF-β1 Autocrine Loop to Induce Fibrosis in Graves' Orbitopathy. [PDF]

Invest Ophthalmol Vis Sci
Bao X, Xu Z, Wang X, Zhang T, Sha X, Sun A, Ye H, Yang H.   +7 more
europepmc   +1 more source

Significance of HLA in the development of Graves' orbitopathy. [PDF]

Genes Immun, 2023
Stasiak M, Zawadzka-Starczewska K, Tymoniuk B, Stasiak B, Lewiński A.   +4 more
europepmc   +1 more source

PDK2-enhanced glycolysis aggravates fibrosis via IL11 signaling pathway in Graves' orbitopathy. [PDF]

Front Immunol
Peng Z, Huang R, Gan L, Wang J, Li X, Ding J, Han Y, Wu J, Xue K, Guo J, Zhang R, Qian J, Ma R.   +12 more
europepmc   +1 more source

Sight‐threatening Graves’ orbitopathy: Twenty years’ experience of a multidisciplinary thyroid‐eye outpatient clinic

, 2018
Blandine Tramunt, P Imbert, Solange Grunenwald, F Boutault, Philippe Caron   +4 more
openalex   +1 more source

Impact of ibrutinib on inflammation in a mouse model of Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Kim C, Park JH, Choi YJ, Jun HO, Chung JK, Park TK, Yoon JS, Yang JW, Jang SY.   +8 more
europepmc   +1 more source

Double motion of upper eyelids in Graves’ orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies

, 2011
Hirohiko Kakizaki, Yasuhiro Takahashi, Masayoshi Iwaki, et al   +3 more
openalex   +1 more source

Long-term outcome of Graves' orbitopathy following treatment with sirolimus. [PDF]

J Endocrinol Invest
Comi S, Cosentino G, Lanzolla G, Menconi F, Maglionico MN, Posarelli C, Latrofa F, Rocchi R, Figus M, Santini F, Marinò M.   +10 more
europepmc   +1 more source

Concomitant Exacerbation of Graves Orbitopathy and Double-Seronegative Myasthenia Gravis after SARS-CoV-2 Infection. [PDF]

JCEM Case Rep
Nakano Y, Takeshima K, Furukawa Y, Morita S, Sakata M, Matsuoka TA.   +5 more
europepmc   +1 more source

Dermis-Fat Graft for Correction of Recurrent Severe Upper Eyelid Retraction in Graves’ Orbitopathy

, 2018
Biljana Kuzmanović Elabjer
openalex   +2 more sources

Therapeutic role of histone deacetylase inhibition in an in vitro model of Graves' orbitopathy. [PDF]

Mol Med Rep
Byeon HJ, Choi SH, Kikkawa DO, Ko J, Yoon JS.   +4 more
europepmc   +1 more source